-+ 0.00%
-+ 0.00%
-+ 0.00%

Bolt Biotherapeutics Files Initial Beneficial Ownership Statement for Director and Chief Strategy Officer Sheila Gujrathi

PUBT·10/27/2026 21:21:14
Listen to the news
Bolt Biotherapeutics Files Initial Beneficial Ownership Statement for Director and Chief Strategy Officer Sheila Gujrathi
  • Bolt Biotherapeutics director and Chief Strategy Officer Sheila Gujrathi filed an initial beneficial ownership statement dated Oct. 27, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bolt Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-434466), on October 27, 2026, and is solely responsible for the information contained therein.